Cachet Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000SN0
CNY
15.40
1.8 (13.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
5,012.61
4,670.90
5,519.42
5,639.68
5,378.30
7,431.89
8,195.51
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,012.61
4,670.90
5,519.42
5,639.68
5,378.30
7,431.89
8,195.51
Raw Material Cost
4,740.09
4,375.72
5,113.94
5,277.73
5,079.20
7,067.33
7,761.96
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
23.69
23.01
28.33
27.04
30.62
32.01
28.32
Selling and Distribution Expenses
156.40
165.42
307.03
192.05
199.04
192.80
267.44
Other Expenses
-2.37
-2.30
-2.83
-2.70
-3.06
-3.20
-2.83
Total Expenditure (Excl Depreciation)
4,896.49
4,541.14
5,420.97
5,469.78
5,278.24
7,260.14
8,029.40
Operating Profit (PBDIT) excl Other Income
116.1
129.8
98.4
169.89999999999998
100.1
171.8
166.1
Other Income
27.80
0.88
48.62
2.75
144.63
17.94
5.58
Operating Profit (PBDIT)
172.15
156.42
62.85
188.21
317.79
259.23
215.83
Interest
23.69
23.01
28.33
27.04
30.62
32.01
28.32
Exceptional Items
-0.01
-0.02
0.02
0.01
-0.02
0.02
-40.05
Gross Profit (PBDT)
272.52
295.18
405.48
361.95
299.11
364.55
433.55
Depreciation
25.38
25.38
13.56
13.56
65.67
65.67
74.79
Profit Before Tax
123.07
108.02
20.99
147.62
221.48
161.58
72.66
Tax
35.69
32.89
60.14
39.49
86.13
44.22
55.92
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
61.11
46.15
-70.31
62.76
92.69
75.53
13.20
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
61.11
46.15
-70.31
62.76
92.69
75.53
13.20
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
26.27
28.98
31.15
45.37
42.66
41.82
3.64
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
87.38
75.13
-39.16
108.13
135.35
117.35
16.84
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,384.31
4,372.79
4,326.64
4,395.66
4,332.90
4,316.06
4,240.53
Earnings per share (EPS)
0.21
0.16
-0.24
0.22
0.32
0.26
0.05
Diluted Earnings per share
0.21
0.16
-0.24
0.22
0.32
0.26
0.05
Operating Profit Margin (Excl OI)
2.37%
2.79%
0.01%
3.05%
2.0%
2.36%
1.65%
Gross Profit Margin
2.96%
2.86%
0.63%
2.86%
5.34%
3.06%
1.8%
PAT Margin
1.22%
0.99%
-1.27%
1.11%
1.72%
1.02%
0.16%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 7.32% vs -15.37% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 16.38% vs 291.58% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -7.14% vs 995.07% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 3.04% vs -18.73% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Cachet Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
5,012.61
0
5,012.61
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,012.61
0
5,012.61
Raw Material Cost
4,740.09
0
4,740.09
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
23.69
0
23.69
Selling and Distribution Expenses
156.40
0
156.40
Other Expenses
-2.37
0.00
-2.37
Total Expenditure (Excl Depreciation)
4,896.49
0
4,896.49
Operating Profit (PBDIT) excl Other Income
116.12
0.00
116.12
Other Income
27.80
0
27.80
Operating Profit (PBDIT)
172.15
0
172.15
Interest
23.69
0
23.69
Exceptional Items
-0.01
0
-0.01
Gross Profit (PBDT)
272.52
0
272.52
Depreciation
25.38
0
25.38
Profit Before Tax
123.07
0
123.07
Tax
35.69
0
35.69
Provisions and contingencies
0
0
0.00
Profit After Tax
61.11
0
61.11
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
61.11
0
61.11
Share in Profit of Associates
0
0
0.00
Minority Interest
26.27
0
26.27
Other related items
0.00
0.00
0.00
Consolidated Net Profit
87.38
0
87.38
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,384.31
0
4,384.31
Earnings per share (EPS)
0.21
0
0.21
Diluted Earnings per share
0.21
0
0.21
Operating Profit Margin (Excl OI)
2.37%
0%
0.00
2.37%
Gross Profit Margin
2.96%
0%
0.00
2.96%
PAT Margin
1.22%
0%
0.00
1.22%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 501.26 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 7.32% vs -15.37% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -6.80% vs -33.66% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.74 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 16.38% vs 291.58% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -35.40% vs 0.97% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.44 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -7.14% vs 995.07% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -16.63% vs -36.77% in Jun 2024

Quarterly - Interest
Interest 2.37 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 3.04% vs -18.73% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -22.55% vs -20.31% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.37%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024